Vertex Pharmaceuticals Q1 2022 Financial Results

Vertex Pharmaceuticals presents Q1 2022 financial results and updates on its cystic fibrosis pipeline, cell therapy programs, and pain management candidates including VX-548. The presentation covers commercial performance, regulatory progress, and full-year 2022 financial guidance.